4.7 Article

Ultrahigh-Resolution Mass Spectrometry-Based Platform for Plasma Metabolomics Applied to Type 2 Diabetes Research

Journal

JOURNAL OF PROTEOME RESEARCH
Volume 20, Issue 1, Pages 463-473

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.jproteome.0c00510

Keywords

Fourier transform ion cyclotron resonance mass spectrometry; flow injection electrospray; metabolite fingerprinting; plasma metabolomics; diabetes; high-throughput platform

Funding

  1. United States (U.S.) Department of Veterans Affairs Biomedical Laboratory Research and Development (BLRD) Service [I01 BX003700]
  2. UW2020 WARF Discovery Initiative grant from the UW-Madison Office of the Vice Chancellor for Research and Graduate Education
  3. Wisconsin Alumni Research Foundation
  4. National Institutes of Health (NIH) [UL1TR002373, R01 DK102598]
  5. NIH Molecular and Pathology Training Program [T32GM081061, F31HL152647]
  6. NIH Chemistry-Biology Interface Training Program [T32 GM008505]
  7. NIH [R01 GM125085, R01 HL109810, S10 OD018475]

Ask authors/readers for more resources

Metabolomics is increasingly recognized as a preferred method for understanding biological systems' responses to stress, and utilizing FIE-FTICR MS technology allows for efficient analysis of different metabolite features in plasma samples with high reproducibility.
Metabolomics-the endpoint of the omics cascade-is increasingly recognized as a preferred method for understanding the ultimate responses of biological systems to stress. Flow injection electrospray (FIE) mass spectrometry (MS) has advantages for untargeted metabolic fingerprinting due to its simplicity and capability for high-throughput screening but requires a high-resolution mass spectrometer to resolve metabolite features. In this study, we developed and validated a high-throughput and highly reproducible metabolomics platform integrating FIE with ultrahigh-resolution Fourier transform ion cyclotron resonance (FTICR) MS for analysis of both polar and nonpolar metabolite features from plasma samples. FIE-FTICR MS enables high-throughput detection of hundreds of metabolite features in a single mass spectrum without a front-end separation step. Using plasma samples from genetically identical obese mice with or without type 2 diabetes (T2D), we validated the intra and intersample reproducibility of our method and its robustness for simultaneously detecting alterations in both polar and nonpolar metabolite features. Only 5 min is needed to acquire an ultra-high resolution mass spectrum in either a positive or negative ionization mode. Approximately 1000 metabolic features were reproducibly detected and annotated in each mouse plasma group. For significantly altered and highly abundant metabolite features, targeted tandem MS (MS/MS) analyses can be applied to confirm their identity. With this integrated platform, we successfully detected over 300 statistically significant metabolic features in T2D mouse plasma as compared to controls and identified new T2D biomarker candidates. This FIE-FTICR MS-based method is of high throughput and highly reproducible with great promise for metabolomics studies toward a better understanding and diagnosis of human diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available